December 18, 2020

Sami-Sabinsa Group, a pioneer and global leader in health science was honored with the Best Patent Portfolio award in SME (Life Science and Pharma) and Best Trademark Portfolio in SME (Life Science and Pharma) at CII Industrial Intellectual Property Awards held virtually on December 18, 2020.

CII Industrial Intellectual Property (IP) Award is the recognition and celebration of Indian enterprises which have embraced IP generation and protection to fuel their economic growth and lend a hand towards the country’s economic progress. The purpose of these awards is to encourage organizations to foster a culture of IP and its commercialization, bring the achievements of enterprises in public domain, set up linkages with academic and research institutions in India and abroad, inform the government about IP-driven enterprises and engage such enterprises in policy making exercises.

“These awards are a recognition of the pioneering work accomplished in the IP domain by the Sami-Sabinsa team.” said Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group. “With research at the core of everything we do, Sami-Sabinsa continues to develop innovative, patented nutraceutical and cosmeceutical products for our clients globally.”